Osteofos 35mg Tablet

Osteofos 35mg Tablet is a prescription-only oral bisphosphonate medication used for the treatment and prevention of osteoporosis in postmenopausal women and men. It is also indicated for patients at risk of developing bone fractures due to low bone mineral density (BMD) and other metabolic bone diseases such as Paget’s disease.

Belonging to the bisphosphonate class, alendronate works by inhibiting osteoclast-mediated bone resorption, thereby helping the body maintain or increase bone mass and density. Over time, it reduces the risk of fractures, particularly in the spine, hip, and wrist.

Osteofos 35mg Tablet is typically prescribed as a once-weekly dose, which is convenient and improves adherence for long-term therapy. It is widely recommended in clinical guidelines as a first-line therapy for osteoporosis, especially in:

• Postmenopausal women

• Men with primary or secondary osteoporosis

• Individuals taking long-term corticosteroids

• Patients with a family history of osteoporotic fractures

This formulation is ideal for those who prefer a weekly dosing regimen instead of daily tablets, reducing the pill burden while maintaining clinical efficacy.